Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 9Breast Neoplasms 6Neoplasms 4Colorectal Neoplasms 3Multiple Myeloma 2Insulin Resistance 2Cardiotoxicity 2Weight Loss 1Warts 1Skin Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Fatigue 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1Cachexia 1Brenner Tumor 1Bone Metastases 1Body Weight 1

Interventions

N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Cryotherapy 2Cholecalciferol 2Cantharidin 22-Propanol 2plerixafor 1methyl 5-aminolevulinate 1green tea extract polyphenone E 1VP-102 1Sugars 1Photochemotherapy 1PRA1 protein, Candida albicans 1Measles-Mumps-Rubella Vaccine 1Maltose 1Interferon-alpha 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Exercise 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Warts × Exercise × Clear all
NCT03691831 2020-10-27

A Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed
502 enrolled 22 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡